I Sahin

No ORCID on file · 1 paper in corpus
rct 2003
International Journal of Gynecology & Obstetrics ·doi:10.1016/s0020-7292(03)00260-1

OBJECTIVES: To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea. METHODS: Fifty-five patients were included in this randomized, placebo-controlled, cross-over study. Pa…